From chloroquine to artemisinin-based combination therapy: the Sudanese experience. - Wikidata - awgldk - TriplyDB

From chloroquine to artemisinin-based combination therapy: the Sudanese experience.

From chloroquine to artemisinin-based combination therapy: the Sudanese experience.

http://www.wikidata.org/entity/Q35065971

about

Drug-resistant malaria in Sudan: A review of evidence and scenarios for the future Mitigating the threat of artemisinin resistance in Africa: improvement of drug-resistance surveillance and response systems High efficacy of artemether-lumefantrine and declining efficacy of artesunate + sulfadoxine-pyrimethamine against Plasmodium falciparum in Sudan (2010-2015): evidence from in vivo and molecular marker studies Impact of home-based management of malaria on health outcomes in Africa: a systematic review of the evidence Malaria treatment policy change in Uganda: what role did evidence play?The roles and influence of actors in the uptake of evidence: the case of malaria treatment policy change in Uganda.Adherence to Artesunate-Amodiaquine Therapy for Uncomplicated Malaria in Rural Ghana: A Randomised Trial of Supervised versus Unsupervised Drug Administration Frequency distribution of antimalarial drug resistance alleles among Plasmodium falciparum isolates from Gezira State, central Sudan, and Gedarif State, eastern Sudan.Progress towards implementation of ACT malaria case-management in public health facilities in the Republic of Sudan: a cluster-sample survey Concomitant malaria among visceral leishmaniasis in-patients from Gedarif and Sennar States, Sudan: a retrospective case-control study.An interactive model for the assessment of the economic costs and benefits of different rapid diagnostic tests for malaria Anti-malarial prescribing practices in Sudan eight years after introduction of artemisinin-based combination therapies and implications for development of drug resistance.Do frontline health care providers know enough about artemisinin-based combination therapy to rationally treat malaria? A cross-sectional survey in Gezira State, Sudan.Malaria treatment policy change and implementation: the case of Uganda.Paediatric malaria case-management with artemether-lumefantrine in Zambia: a repeat cross-sectional study.A comparative study on the efficacy of artesunate plus sulphadoxine/pyrimethamine versus artemether-lumefantrine in eastern Sudan.Policy dialogue to improve health outcomes in low income countries: what are the issues and way forward?Pharmacokinetic profiles of artesunate following multiple intravenous doses of 2, 4, and 8 mg/kg in healthy volunteers: phase 1b study Efficacy of artemether-lumefantrine as a treatment for uncomplicated Plasmodium vivax malaria in eastern Sudan Predicting Global Fund grant disbursements for procurement of artemisinin-based combination therapies.Cost of increasing access to artemisinin combination therapy: the Cambodian experience.Malaria research and its influence on anti-malarial drug policy in Malawi: a case study.Selection of pfdhfr/pfdhps alleles and declining artesunate/sulphadoxine-pyrimethamine efficacy against Plasmodium falciparum eight years after deployment in eastern Sudan.Multiplicity of infection and genetic diversity of Plasmodium falciparum isolates from patients with uncomplicated and severe malaria in Gezira State, Sudan.Time to switch from quinine Extended high efficacy of the combination sulphadoxine-pyrimethamine with artesunate in children with uncomplicated falciparum malaria on the Benin coast, West Africa.Health service providers in Somalia: their readiness to provide malaria case-management.Insecticide susceptibility and vector status of natural populations of Anopheles arabiensis from Sudan.Impact of insecticide resistance in Anopheles arabiensis on malaria incidence and prevalence in Sudan and the costs of mitigation.Improper protein trafficking contributes to artemisinin sensitivity in cells lacking the KDAC Rpd3p.Efficacy and safety of artemisinin-based combination therapy for uncomplicated Plasmodium falciparum malaria in Sudan: a systematic review and meta-analysis.

P2860

Q26860010-78C62164-2BD3-4AD6-ACC6-45192CA3EF0B Q27000750-98EB5EFF-BB72-4D49-B19E-0516DE903311 Q28125935-8C456554-F275-4154-B8C7-CFD3A38071D0 Q28222513-607A926A-44F6-40C5-9188-49A75ABB6999 Q30586992-44B4EAE0-BBD7-40A1-8AEA-20139A723E58 Q30591337-970EA53C-293D-4854-B22C-382D2A2C2485 Q33720881-BC9B6768-7CF5-47D6-ACE7-A1FBE49BC015 Q34024767-978CC9C8-E3C9-45D6-BE85-F867D7E63916 Q34119570-74103140-3461-458B-89DA-9DE733CE6E9A Q34664551-CA805615-EE17-402E-B707-1BD0DA6258E7 Q34742701-5FA35A57-073D-4EF2-9132-365C97A6557B Q35226071-518E42DE-75FF-4A43-8BBA-B828D6DB349E Q35226099-1B4A1ADE-0F78-41D6-A829-5D07E10C40D9 Q35692263-01B8CF0D-7BB0-4BCF-97B4-15F1A09A73CF Q35699632-939D9DD8-8087-4E5C-BD7B-DC8AAA0803BA Q35925276-3315B12C-05E1-4F1C-91E3-083A50AE90C1 Q36084804-8A7BD23E-371C-4C86-BD1E-D6E43073DA14 Q36309099-6ABBFBCA-EBF6-4281-917C-D8E68796B32A Q36459402-1B9BF9F0-896B-49FA-B368-6FAE898BB493 Q36511836-C29361CE-3ADE-41E6-A7EE-083704E10013 Q36700468-7BA0B83D-D468-4980-A15B-E8B732768A1B Q36955257-43F1FE29-811F-4A57-8F11-1BB3FA6359E1 Q37038288-09901C87-93AD-4819-A7DA-365838549D4D Q37045302-63E94F8B-C114-4683-80F0-832F7C7CB5AD Q37105902-729E2A45-547A-4385-A1CE-472A1E2035BC Q37121532-33B75CC6-F809-4A17-BA2A-5E43BAD6E0A5 Q37207676-3D531A58-EF72-452B-BF6C-5EF1C272C618 Q44138939-6DD43C25-DFA4-4D73-8B4D-A66C0C59C87E Q47327401-269972D9-6FA3-4682-9E62-4CEB40B9B214 Q47884901-0EDA25E0-3FF2-47E1-AF73-80D72FC45318 Q53702337-7850D7B5-7ECD-4EE1-8C95-4B7D868B2D4C

P2860

From chloroquine to artemisinin-based combination therapy: the Sudanese experience.

http://www.wikidata.org/entity/Q35065971

description

2006 nî lūn-bûn

@nan

2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

From chloroquine to artemisinin-based combination therapy: the Sudanese experience.

@ast

From chloroquine to artemisinin-based combination therapy: the Sudanese experience.

@en

type

label

From chloroquine to artemisinin-based combination therapy: the Sudanese experience.

@ast

From chloroquine to artemisinin-based combination therapy: the Sudanese experience.

@en

prefLabel

From chloroquine to artemisinin-based combination therapy: the Sudanese experience.

@ast

From chloroquine to artemisinin-based combination therapy: the Sudanese experience.

@en

P1433

Q35065971-DDBCECA5-30C9-4FA6-A572-84D40C92C53B

P1476

Q35065971-D7BA5D34-A309-4248-8034-36C4DF53A626

P2093

Q35065971-08E0C446-7169-4FAF-AA10-8E3D12841A06

Q35065971-3030F673-ADF1-40F7-A1F1-98E9EB84A83A

Q35065971-585251F0-67D2-4692-8720-7E7F65AFD2CB

Q35065971-6EA5E1F5-E25A-4122-B6BD-3F67C877A11C

Q35065971-7A9FE07D-A9F1-4AF4-BD4D-D8839CBC1A25

Q35065971-C019E1BE-F4A4-4C18-B4E7-383D124D9537

Q35065971-D4DCA656-6B4E-4516-A8D6-7E260ACF6761

Q35065971-E1A969C0-1C7E-4387-B90E-69C1C748D3AF

P2860

Q35065971-01DA6E75-74A7-4BBA-A5A7-9A335CEF30C9

Q35065971-047C71B1-1376-41F6-81E2-CA060AA72FC2

Q35065971-057C2E76-AE62-4B5A-BB57-5B73154DAF44

Q35065971-0D46CA10-EA1F-48E8-9C8B-6960EF916CB3

Q35065971-1154BB41-B7AA-419B-B2E4-05A306F9B064

Q35065971-143C6EDD-216F-4930-8902-C714716572DA

Q35065971-2954DA9F-A970-4EFB-B9BE-2BAE95ECB35A

Q35065971-3A04D4E5-AA23-4811-AFA9-121945756B8A

Q35065971-3A8291A9-322B-4A17-9AD7-1AD46C35AFAF

Q35065971-4F7BF377-DF54-45E5-A8EB-37D50B5F3C3A

P2888

Q35065971-94D8BE19-7CEE-4F5C-AE6B-3B04B804407F

P304

Q35065971-924400A8-ACAD-49EC-B22C-E154AF7A654E

P31

Q35065971-F856BD76-1E69-45D8-BBCD-2A6DF501B747

P356

Q35065971-E42E6DCD-F137-4E72-916E-88B27BFB5831

P478

Q35065971-D17C7D0B-7C65-415D-9160-75E3179E0EC9

P577

Q35065971-708A07B9-5EBD-4007-9DA9-DA6C830D4D6F

P5875

Q35065971-8142F0A0-F4F3-42EE-80C2-A3DE52E08881

P6179

Q35065971-B67A83C8-3E4B-4126-B650-F51B3A5EF846

P698

Q35065971-B336F775-35FF-4A05-8B77-97173C1E00C3

P921

Q35065971-06D0FE40-211B-4778-A8A8-847BB18E75AB

Q35065971-7CC74D35-AE2E-460C-B73D-2A98E122368D

P932

Q35065971-AF5021EB-8B18-4E7E-82B6-9105EC2DB9F2

P356

P1433

Malaria Journal

P1476

From chloroquine to artemisinin-based combination therapy: the Sudanese experience.

@en

P2093

A A Mannan

http://www.w3.org/2001/XMLSchema#string

A H Elhassan

http://www.w3.org/2001/XMLSchema#string

E M Malik

http://www.w3.org/2001/XMLSchema#string

E S Ahmed

http://www.w3.org/2001/XMLSchema#string

K A Elmardi

http://www.w3.org/2001/XMLSchema#string

R M Mowien

http://www.w3.org/2001/XMLSchema#string

S B Elamin

http://www.w3.org/2001/XMLSchema#string

T A Mohamed

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy of two artemisinin combination therapies for uncomplicated falciparum malaria in children under 5 years, Malakal, Upper Nile, Sudan

Artesunate plus sulfadoxine-pyrimethamine for treatment of uncomplicated Plasmodium falciparum malaria in Sudan.

Making malaria-treatment policy in the face of drug resistance.

Treatment of paediatric malaria during a period of drug transition to artemether-lumefantrine in Zambia: cross sectional study.

Using evidence to change antimalarial drug policy in Kenya.

Combination therapy for malaria in Africa: hype or hope?

The challenge of chloroquine-resistant malaria in sub-Saharan Africa.

The public health impact of chloroquine resistance in Africa.

Increasing antimalarial drug resistance in Uganda and revision of the national drug policy.

Estimating the needs for artesunate-based combination therapy for malaria case-management in Africa.

P2888

P304

65

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1475-2875-5-65

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2006-07-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6906420

http://www.w3.org/2001/XMLSchema#string

P6179

1005873903

http://www.w3.org/2001/XMLSchema#string

P698

16879742

http://www.w3.org/2001/XMLSchema#string

P921

P932

1590042

http://www.w3.org/2001/XMLSchema#string